Publicacions en col·laboració amb investigadors/es de University of Bologna (10)

2023

  1. Electrocardiogram analysis in Anderson-Fabry disease: a valuable tool for progressive phenotypic expression tracking

    Frontiers in Cardiovascular Medicine, Vol. 10

2020

  1. Mortality among Referral Patients with Hypertrophic Cardiomyopathy vs the General European Population

    JAMA Cardiology, Vol. 5, Núm. 1, pp. 73-80

2019

  1. Corrigendum to Supplemental Material: ‘D242N, a K V 7.1 LQTS mutation uncovers a key residue for I Ks voltage dependence’ [Journal of Molecular and Cellular Cardiology, Volume 110, September 2017, Pages 61–69](S0022282817301633)(10.1016/j.yjmcc.2017.07.009)

    Journal of Molecular and Cellular Cardiology

  2. Effectiveness of the 2014 european society of cardiology guideline on sudden cardiac death in hypertrophic cardiomyopathy: A systematic review and meta-analysis

    Heart, Vol. 105, Núm. 8, pp. 623-631

2017

  1. D242N, a KV7.1 LQTS mutation uncovers a key residue for IKs voltage dependence

    Journal of Molecular and Cellular Cardiology, Vol. 110, pp. 61-69

  2. Predictors of atrial fibrillation in hypertrophic cardiomyopathy

    Heart, Vol. 103, Núm. 9, pp. 672-678

2016

  1. Inverted U-Shaped Relation between the Risk of Sudden Cardiac Death and Maximal Left Ventricular Wall Thickness in Hypertrophic Cardiomyopathy

    Circulation: Arrhythmia and Electrophysiology, Vol. 9, Núm. 6

2015

  1. A new KCNQ1 mutation at the S5 segment that impairs its association with KCNE1 is responsible for short QT syndrome

    Cardiovascular Research, Vol. 107, Núm. 4, pp. 613-623

  2. Prediction of thrombo-embolic risk in patients with hypertrophic cardiomyopathy (HCM Risk-CVA)

    European Journal of Heart Failure, Vol. 17, Núm. 8, pp. 837-845

2014

  1. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD)

    European Heart Journal, Vol. 35, Núm. 30, pp. 2010-2020